Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

imiquimod

View Patient Information
A synthetic agent with immune response modifying activity. As an immune response modifier (IRM), imiquimod stimulates cytokine production, especially interferon production, and exhibits antitumor activity, particularly against cutaneous cancers. Imiquimod's proapoptotic activity appears to be related to Bcl-2 overexpression in susceptible tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Aldara
Zyclara
Abbreviation:IMQ
Code name:R 837
S 26308
Chemical structure:1H-imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-
4-amino-1-isobutyl-1H-imidazo(4,5-c)quinoline
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search